Acta Haematol. 2024;147(2):229-246. doi: 10.1159/000536152. Epub 2024 Feb 16.
PMID:38228114
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
Patnaik MM, Tefferi A.
Am J Hematol. 2024 Jun;99(6):1142-1165. doi: 10.1002/ajh.27271. Epub 2024 Mar 7.
PMID:38450850
Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia.
Cui B, Ai L, Lei M, Duan Y, Tang C, Zhang J, Gao Y, Li X, Zhu C, Zhang Y, Zhu X, Isobe T, Yang W, Göttgens B, Zhu P.
Blood. 2025 Mar 13;145(11):1211-1224. doi: 10.1182/blood.2024025618.
PMID:39661948
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia.
Hasserjian RP, Steensma DP, Graubert TA, Ebert BL.
Blood. 2020 May 14;135(20):1729-1738. doi: 10.1182/blood.2019004770.
PMID:32232484
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.
Sperotto A, Bochicchio MT, Simonetti G, Buccisano F, Peccatori J, Piemontese S, Calistri E, Ciotti G, Pierdomenico E, De Marchi R, Ciceri F, Gottardi M.
Biomedicines. 2023 Jan 26;11(2):359. doi: 10.3390/biomedicines11020359.
PMID:36830896
TET2-mutant myeloid cells mitigate Alzheimer's disease progression via CNS infiltration and enhanced phagocytosis in mice.
Matatall KA, Wathan TK, Nguyen M, Chen H, McDonald A, Qi G, Belk JA, Florez MA, Le DT, Olarinde T, Vlasschaert C, Buttigieg MM, Fan CW, Carcamo S, Cao R, Kennedy DE 2nd, Maknojia AA, Thatavarty A, Fernandez Sanchez JV, Bouzid H, Veeraragavan S, Crocker S, Goodell MA, Rodriguez A, Jaiswal S, Rauh MJ, Papapetrou EP, Marro SG, King KY.